|
regulation of cell-cell adhesion mediated by cadherin
|
GO_2000047 |
[Any process that modulates the frequency, rate or extent of cell-cell adhesion mediated by cadherin.] |
|
negative regulation of cell-cell adhesion mediated by cadherin
|
GO_2000048 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of cell-cell adhesion mediated by cadherin.] |
|
regulation of G1/S transition of mitotic cell cycle
|
GO_2000045 |
[Any signaling pathway that modulates the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the mitotic cell cycle.] |
|
regulation of cell cycle G1/S phase transition
|
GO_1902806 |
[Any signaling pathway that modulates the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the cell cycle.] |
|
obsolete regulation of G2 phase of mitotic cell cycle
|
GO_2000046 |
[OBSOLETE. Any process that modulates the frequency, rate or extent of G2 phase of mitotic cell cycle.] |
|
response to 5-fluoro-2'-deoxyuridine
|
GO_0097330 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 5-fluoro-2'-deoxyuridine stimulus. 5-fluoro-2'-deoxyuridine is a pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; it is used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.] |
|
response to cytarabine
|
GO_0097331 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytarabine stimulus.] |
|
response to glycoside
|
GO_1903416 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glycoside stimulus.] |
|
response to antipsychotic drug
|
GO_0097332 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antipsychotic drug stimulus. Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.] |
|
obsolete regulation of planar cell polarity pathway involved in axis elongation
|
GO_2000040 |
[OBSOLETE. Any process that modulates the frequency, rate or extent of planar cell polarity pathway involved in axis elongation.] |
|
response to olanzapine
|
GO_0097333 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an olanzapine stimulus.] |
|
response to perphenazine
|
GO_0097334 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a perphenazine stimulus. Perphenazine is a phenothiazine derivative having a chloro substituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at the N-10 position.] |
|
response to quetiapine
|
GO_0097335 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a quetiapine stimulus.] |
|
response to risperidone
|
GO_0097336 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a risperidone stimulus.] |
|
response to ziprasidone
|
GO_0097337 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ziprasidone stimulus. Ziprasidone is a piperazine compound having 1,2-benzothiazol-3-yl- and 2-(6-chloro-1,3-dihydro-2-oxindol-5-yl)ethyl substituents attached to the nitrogen atoms.] |
|
response to clozapine
|
GO_0097338 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a clozapine stimulus.] |
|
glycolate transmembrane transport
|
GO_0097339 |
[The process in which glycolate is transported across a membrane. Glycolate is the anion of hydroxyethanoic acid (glycolic acid).] |
|
glycolate transport
|
GO_1900866 |
[The directed movement of a glycolate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.] |
|
positive regulation of cell-cell adhesion mediated by cadherin
|
GO_2000049 |
[Any process that activates or increases the frequency, rate or extent of cell-cell adhesion mediated by cadherin.] |
|
obsolete negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification
|
GO_2000054 |
[OBSOLETE. Any process that stops, prevents, or reduces the frequency, rate or extent of Wnt signaling pathway involved in dorsal/ventral axis specification.] |